Teleradioterapija kostnih zasevkov
Teleradiotherapy of bone metastases
Keywords:
teleradiotherapy, bones, solid tumors, bone metastasesAbstract
Kosti so tretje najpogostejše mesto zasevanja solidnih tumorjev. Zapleti na skeletu kot posledica zasevkov zmanjšujejo kakovost bolnikovega življenja, njegovo mobilnost in povečajo stroške zdravljenja.Radioterapija ostaja najpomembnejša paliativna metoda zdravljenja bolečih kostnih zasevkov. Izbor tako modalitete kot tudi režima obsevanja je individualiziran glede na bolnikovo klinično stanje, pričakovano življenjsko dobo in kakovost življenja. V prispevku je podan pregled paliativnega zdravljenja kostnih zasevkov s teleradioterapijo.
Abstract (Eng)
The bone is the third most common site of metastasis of solid tumours. As a result of metastases, complications on the skeleton reduce the quality of life of patients, their mobility and increase the cost of treatment.Radiation therapy remains the most important palliative method for the treatment of painful bone metastases. The selection of both the modality and the irradiation regime is individualised, depending on the patient's clinical status, life expectancy and quality of life. This paper gives a review of palliative treatment of bone metastases using teleradiotherapy.
Downloads
Published
How to Cite
Issue
Section
License
The journal is published under the terms of the Creative Commons Attribution License CC-BY 4.0. The authors retain the copyright to their work without any restrictions whatsoever.
This journal is an open-access journal, meaning that all of its contents are freely accessible without any charge to the user or their institution. In accordance with the Budapest Open Access Initiative (BOAI) definition of open access, users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking for prior permission from the publisher or the author, provided the authors and the journal are appropriately credited.









